JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dren, A. T.
Right arrow Articles by Domino, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dren, A. T.
Right arrow Articles by Domino, E. F.
Journal of Pharmacology And Experimental Therapeutics, Vol. 161, Issue 1, 141-154, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF HEMICHOLINITJM (HC-3) ON EEG ACTIVATION AND BRAIN ACETYLCHOLINE IN THE DOG

Anthony T. Dren 1 and Edward F. Domino 1

1 Department of Pharmacology, University of Michigan, Ann Arbor, Michigan

The present study was designed to determine whether HC-3, a potent inhibitor of choline uptake and therefore of acetylcholine (ACh) synthesis, could provide additional evidence that cholinergic neurons are involved in the neocortical and limbic EEG activating systems. The effects of HC-3 were determined on the EEG and brain ACh content of locally anesthetized, decamethonium-immobilized, artificially respired dogs. Intravenous HC-3 (5 and 10 mg/kg) did not produce consistent EEG effects. To circumvent the blood-brain barrier, HC-3 was administered intraventricularly into the left lateral cerebral ventricle in total doses of 1.0 µg to 5.0 mg. No obvious change in EEG activity occurred after the 1.0-µg dose. After 10 µg, high voltage, spike-like slow waves appeared in the amygdala without the occurrence of concomitant EEG changes in the neocortex. The initial effects produced by 50 µg to 1.25 mg were characterized by high voltage hippocampal fast waves in addition to amygdaloid slow waves. EEG seizures frequently occurred after 2.5 and 5.0 mg. Two to 4 hr after 50 µg to 5.0 mg, high voltage neocortical slow waves appeared. Once slow waves were present, high frequency electrical and peripheral nociceptive stimulation of the mesencephalic reticular formation and posterior hypothalamus no longet elicited an activation response. Although EEG activation elicited by high frequency stimulation of the diffuse thalamic projection system was also prevented, recruiting responses recorded in the neocortex and caudate nucleus by low frequency stimulation of the same thalamic areas were only slightly modified. Choline (5-50 mg/kg i.v.) produced a delayed and transient reversal of the HC-3 effects. A significant decrease (41-79% in the ACh content of the amygdala, hippocampus, medial thalamus, reticular formation and caudate nucleus occurred 4 hr after 50 µg and 5.0 mg of HC-3 intraventricularly. Neocortical ACh levels were not altered significantly. Similar effects did not occur 1 hr after 50 µg of HC-3 intraventricularly or 4 hr after 5.0 and 10 mg/kg of HC-3 i.v. It is concluded that the effect of HC-3 on EEG activation is associated with reduction of cerebral ACh. However, an action of HC-3 on other choline-containing substances in the brain was not ruled out as a possible mechanism of action.

Submitted on July 26, 1967
Accepted on January 18, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.